Biosimilars

Bioanalytical Lab

Full-Spectrum Offerings

Pharmacokinetic Assessment

Immunogenicity Assessment

PD/Biomarker Evaluation

Toxicokinetic Measurement

Method Development

Pharmacokinetic Assessment

The Lambda Advantage

Bioanalytical expertise
  • PK assays
  • Immunogenicity assays (ADA)
  • Neutralizing Antibody (NAb) Assays 
  • Pharmacodynamic (PD) Biomarker Assays
Analytical Platforms
  • Enzyme-Linked Immunosorbent Assays (ELISA)
  • Electrochemiluminescent Assays (ECLIA)
  • In-vitro diagnostics (for Biomarkers)
  • MSD Reader
  • Cell Based Assays (for NAb)
  • Flow Cytometry
Value Additions
  • Antibody sourcing & Antigen Affinity-based purification.
  • Conjugations: Biotin, Digoxigenin, HRP, Ruthenium

Extensive Experience

Adalimumab

Bevacizumab

Denosumab

Filgrastim

Vedolizumab

GCSF

Glucagon

Pegfilgrastim

PEG G-CSF

Pertuzumab

Ranibizumab

Rituximab

rHu-FSH

Teriparatide

Trastuzumab

Romiplostim

Follicle-stimulating hormone (FSH)

Ligand-Binding Assays

Cell-based Assays

Our Presence

We see the current vigorous growth the Group and are confident about